Clinical activity, safety, and PK/PD from a phase I study of RO6874281, a fibroblast activation protein (FAP) targeted interleukin-2 variant (IL-2v)

Affiliation auteurs!!!! Error affiliation !!!!
TitreClinical activity, safety, and PK/PD from a phase I study of RO6874281, a fibroblast activation protein (FAP) targeted interleukin-2 variant (IL-2v)
Type de publicationJournal Article
Year of Publication2018
AuteursMelero I., E. Alvarez C, Mau-Sorensen M., Lassen U.N, Lolkema M.P, Robbrecht D.G, Gomez-Roca C.A, Martin-Liberal J., Tabernero J., Ros W., Ahmed S., Isambert N., H. Lepoutre P, Boetsch C., Charo J., Evers S., Teichgraber V., Schellens J.HM
JournalANNALS OF ONCOLOGY
Volume29
Date PublishedOCT
Type of ArticleMeeting Abstract
ISSN0923-7534